Mackenzie Financial Corp Gsk PLC Transaction History

Mackenzie Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$37.8 - $42.69 $1.04 Million - $1.18 Million	-27,546 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$39.75 - $42.69 $5,167 - $5,549	-130 Reduced 0.47%	27,546 $1.11 Million
Q2 2018 Aug 13, 2018	BUY	$39.61 - $42.76 $440,383 - $475,405	11,118 Added 67.15%	27,676 $1.12 Million
Q1 2018 May 14, 2018	BUY	$36.18 - $40.15 $94,646 - $105,032	2,616 Added 18.76%	16,558 $647,000
Q4 2017 Feb 13, 2018	BUY	$35.34 - $41.9 $139,805 - $165,756	3,956 Added 39.62%	13,942 $495,000
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $22,678 - $23,891	575 Added 6.11%	9,986 $405,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,411	9,411 $406,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $83.1B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.